Who founded Transcriptic?

Transcriptic was founded by Max Hodak.

Who are Transcriptic's investors?

Transcriptic's investors include GV (Google Ventures), Mission and Market, Y Combinator, 500 Global, AME Cloud Ventures, DCVC (Data Collective), Digital Science, IA Ventures.

Where is Transcriptic headquartered?

Transcriptic is headquartered in San Francisco, US.

Transcriptic

DefunctYC W15

San Francisco, US · 13 employees · 8 known investors

Find your way into Transcriptic

Paths you didn't know you had: your email and LinkedIn already hold routes to the Transcriptic team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Strateos operates a cloud lab platform offering laboratory automation-as-a-service, using high-throughput robotics that let scientists design, run, and analyze experiments remotely via a web browser. It serves pharmaceutical companies, biotechs, startups, academia, CROs, and AI drug discovery teams in the life sciences.

Also known as Strateos, Inc.

AI & Machine Learning Biotech Healthtech RoboticsUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W15)

Max Hodak Founder & CEO2012–2017Max Hodak studied biomedical engineering at Duke, where he conducted electrophysiology research on brain-machine interfaces. He is founder and CEO of Transcriptic (now Strateos), a cloud laboratory platform that provides automated experimentation services to life science researchers.30 Under 30 2015

Mark Fishcher-ColbrieCEO

Investors · 8

GV (Google Ventures)listed by GV (Google Ventures)Mountain View · $250K – $50M

How we know: GV (Google Ventures)'s portfolio page · Y Combinator's founder network · open dataset · 5k.vc investor directory · Not right? Tell us

Mission and Marketlisted by Mission and MarketSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

500 GlobalreportedPalo Alto · $150K

How we know: funding news · Y Combinator's founder network · Not right? Tell us

AME Cloud VenturesreportedPalo Alto · $1M – $10M

How we know: funding news · Y Combinator's founder network · Not right? Tell us

DCVC (Data Collective)reportedPalo Alto · $5M – $25M

How we know: Y Combinator's founder network · Not right? Tell us

Digital SciencereportedLondon

How we know: Y Combinator's founder network · Not right? Tell us

IA VenturesreportedNew York · $1M – $3M

How we know: Y Combinator's founder network · Not right? Tell us

Funding

SEC filings, press & company announcements

Undisclosed amountSeries AFeb 2015
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

3 people who came through Transcriptic went on to found or lead other companies.

Max HodakCEOFounded Neuralink-LogoArtboard-1 +1 Jeffrey FinerBoard MemberFounded Septerna Mukund TibrewalaSoftware Engineering InternFounded Salient

Related companies · 5

NeuromorphicNeuromorphic develops hardware-agnostic control software for robots, letting operators deploy and manage them through everyday interfaces such as Slack, email, and phone. It targets wet labs and other physical industries that want to add robots with minimal setup.

OpentronsOpentrons develops laboratory robots that automate scientific research tasks for scientists and research institutions. The company aims to democratize access to laboratory automation and increase the availability of robotic systems to accelerate discovery in life sciences.

Reshape BiotechReshape provides an AI-driven operating system that automates microbiology data capture and analysis for research laboratories. The platform structures experimental results and surfaces insights to help lab teams accelerate research and product development.

Kiwi BiosciencesFODZYME develops an enzyme powder supplement that breaks down FODMAPs in food, particularly fructans found in garlic, onions, and wheat, for people with digestive sensitivities. The product targets individuals who need to manage FODMAP intolerance to improve their diet flexibility and quality of life.

Future FieldsFuture Fields uses fruit flies as bioreactors to produce difficult-to-express proteins at scale for pharmaceutical, agricultural, and food applications. The company aims to enable the development of novel biological products across healthcare, agriculture, and nutrition sectors.

Companies working in the same space as Transcriptic.

Legal entities · 2

corporate structure

Strateos, Inc.

Transcriptic, Inc.

In the news

Cloud-Based Bio Lab Transcriptic (YC W15) Lands $8.5M in Series A Fundingtechcrunch.com · Feb 2015

Frequently asked questions

What does Transcriptic do?: Strateos operates a cloud lab platform offering laboratory automation-as-a-service, using high-throughput robotics that let scientists design, run, and analyze experiments remotely via a web browser. It serves pharmaceutical companies, biotechs, startups, academia, CROs, and AI drug discovery teams in the life sciences.
Who founded Transcriptic?: Transcriptic was founded by Max Hodak.
Who are Transcriptic's investors?: Transcriptic's investors include GV (Google Ventures), Mission and Market, Y Combinator, 500 Global, AME Cloud Ventures, DCVC (Data Collective), Digital Science, IA Ventures.
Where is Transcriptic headquartered?: Transcriptic is headquartered in San Francisco, US.